Literature DB >> 12057982

Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.

J H F Rudd1, E A Warburton, T D Fryer, H A Jones, J C Clark, N Antoun, P Johnström, A P Davenport, P J Kirkpatrick, B N Arch, J D Pickard, P L Weissberg.   

Abstract

BACKGROUND: Atherosclerotic plaque rupture is usually a consequence of inflammatory cell activity within the plaque. Current imaging techniques provide anatomic data but no indication of plaque inflammation. The glucose analogue [18F]-fluorodeoxyglucose (18FDG) can be used to image inflammatory cell activity non-invasively by PET. In this study we tested whether 18FDG-PET imaging can identify inflammation within carotid artery atherosclerotic plaques. METHODS AND
RESULTS: Eight patients with symptomatic carotid atherosclerosis were imaged using 18FDG-PET and co-registered CT. Symptomatic carotid plaques were visible in 18FDG-PET images acquired 3 hours post-18FDG injection. The estimated net 18FDG accumulation rate (plaque/integral plasma) in symptomatic lesions was 27% higher than in contralateral asymptomatic lesions. There was no measurable 18FDG uptake into normal carotid arteries. Autoradiography of excised plaques confirmed accumulation of deoxyglucose in macrophage-rich areas of the plaque.
CONCLUSIONS: This study demonstrates that atherosclerotic plaque inflammation can be imaged with 18FDG-PET, and that symptomatic, unstable plaques accumulate more 18FDG than asymptomatic lesions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12057982     DOI: 10.1161/01.cir.0000020548.60110.76

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  378 in total

1.  Cardiovascular disease in HIV: traditional and nontraditional risk factors.

Authors:  Steven K Grinspoon
Journal:  Top Antivir Med       Date:  2014 Sep-Oct

Review 2.  Imaging of coronary inflammation with FDG-PET: feasibility and clinical hurdles.

Authors:  Ian S Rogers; Ahmed Tawakol
Journal:  Curr Cardiol Rep       Date:  2011-04       Impact factor: 2.931

Review 3.  Imaging of carotid artery disease: from luminology to function?

Authors:  J H Gillard
Journal:  Neuroradiology       Date:  2003-09-04       Impact factor: 2.804

Review 4.  Magnetic resonance imaging of coronary atherosclerosis.

Authors:  Zahi A Fayad; Robin P Choudhury; Valentin Fuster
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

5.  Second Annual Mario S. Verani, MD, Memorial Lecture: Nuclear cardiology, the next 10 years.

Authors:  Barry L Zaret
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

6.  Imaging of unstable atherosclerotic lesions.

Authors:  Jagat Narula; H William Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-01       Impact factor: 9.236

Review 7.  Human cellular inflammation in the pathology of acute cerebral ischaemia.

Authors:  C J S Price; E A Warburton; D K Menon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

8.  Identification of inflamed atherosclerotic lesions in vivo using PET-CT.

Authors:  Mateja Kaja Jezovnik; Nina Zidar; Luka Lezaic; Borut Gersak; Pavel Poredos
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

9.  The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease.

Authors:  Martin A Walter; Ralph A Melzer; Christian Schindler; Jan Müller-Brand; Alan Tyndall; Egbert U Nitzsche
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-04       Impact factor: 9.236

10.  Subclinical vasculitis as a potential mechanism to explain the heightened cardiovascular risk in rheumatoid arthritis.

Authors:  Zahi A Fayad; Jeffrey D Greenberg; Jan Bucerius
Journal:  Circulation       Date:  2012-10-24       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.